{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:42:52Z","timestamp":1790116972917,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006448","name":"A.H. Schultz-Stiftung zur F\u00f6rderung Primatologischer Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012317","name":"Astellas Pharma Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.healun.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T12:55:05Z","timestamp":1518785705000},"page":"886-894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["A strategy for prevention of fungal infections in lung transplantation: Role of bronchoalveolar lavage fluid galactomannan and fungal culture"],"prefix":"10.1016","volume":"37","author":[{"given":"Shahid","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Bhaskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleman","family":"Rotstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyajahan","family":"Bhimji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Humar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaf","family":"Keshavjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne G.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2018.02.006_bib1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2018.02.006_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.healun.2018.02.006_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.healun.2018.02.006_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-3062.2006.00156.x","article-title":"Variation in antifungal prophylaxis strategies in lung transplantation","volume":"8","author":"Husain","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2018.02.006_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-6143.2010.03375.x","article-title":"Antifungal prophylaxis in lung transplantation\u2014a world-wide survey","volume":"11","author":"Neoh","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/tid.12337","article-title":"Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey","volume":"17","author":"He","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2018.02.006_bib7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11908-013-0380-y","article-title":"Anti-Aspergillus prophylaxis in lung transplantation: a systematic review and meta-analysis","volume":"15","author":"Bhaskaran","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.healun.2018.02.006_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.healun.2016.01.007","article-title":"The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary","volume":"35","author":"Husain","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 4","key":"10.1016\/j.healun.2018.02.006_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ajt.12115","article-title":"Aspergillosis in solid organ transplantation","volume":"13","author":"Singh","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/ajt.13431","article-title":"Voriconazole exposure and risk of cutaneous squamous cell carcinoma, Aspergillus colonization, invasive aspergillosis and death in lung transplant recipients","volume":"16","author":"Mansh","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib11","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/TP.0000000000000743","article-title":"The effectiveness of culture-directed preemptive anti-aspergillus treatment in lung transplant recipients at one year after transplant","volume":"99","author":"Hosseini-Moghaddam","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.02.006_bib12","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/CVI.00226-08","article-title":"Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid","volume":"15","author":"Husain","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.healun.2018.02.006_bib13","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/cid\/cir185","article-title":"Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients","volume":"52","author":"Luong","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2018.02.006_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/ajt.13076","article-title":"Survival in sensitized lung transplant recipients with perioperative desensitization","volume":"15","author":"Tinckam","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib17","first-page":"1","article-title":"Revision of the 1990 working formulation for the classification of pulmonary allograft rejection","volume":"15","author":"Yousem","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib18","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/ctr.12854","article-title":"Is universal antifungal prophylaxis mandatory in adults after lung transplantation? A review and meta-analysis of observational studies","volume":"30","author":"Pilarczyk","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib19","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.healun.2003.09.028","article-title":"A survey of anti-fungal management in lung transplantation","volume":"23","author":"Dummer","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib20","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/TP.0000000000001050","article-title":"Antifungal prophylaxis in lung transplant recipients","volume":"100","author":"Patel","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.02.006_bib21","first-page":"70","article-title":"Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients. Transplant","volume":"18","author":"Peghin","year":"2016","journal-title":"Infect Dis"},{"key":"10.1016\/j.healun.2018.02.006_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/tri.12679","article-title":"10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation","volume":"29","author":"Peghin","year":"2016","journal-title":"Transplant Int"},{"key":"10.1016\/j.healun.2018.02.006_bib23","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1600-6143.2012.04042.x","article-title":"Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients","volume":"12","author":"Luong","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib24","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.healun.2010.05.022","article-title":"Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients","volume":"29","author":"Vadnerkar","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib25","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/j.1600-6143.2009.02837.x","article-title":"Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients","volume":"9","author":"Wang","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.healun.2012.02.033","article-title":"High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients","volume":"31","author":"Singer","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0033-1348475","article-title":"Mold infections in lung transplant recipients","volume":"34","author":"Bhaskaran","year":"2013","journal-title":"Sem Respir Crit Care Med"},{"key":"10.1016\/j.healun.2018.02.006_bib28","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/JCM.00077-07","article-title":"Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients","volume":"45","author":"Clancy","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.healun.2018.02.006_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/TP.0b013e3181e49bc1","article-title":"Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid","volume":"90","author":"Pasqualotto","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.02.006_bib30","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1378\/chest.114.5.1321","article-title":"Pulmonary aspergillosis in cystic fibrosis lung transplant recipients","volume":"114","author":"Nunley","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.healun.2018.02.006_bib31","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1378\/chest.123.3.800","article-title":"Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients","volume":"123","author":"Helmi","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.healun.2018.02.006_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1053-2498(02)00477-1","article-title":"Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management","volume":"22","author":"Singh","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib33","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.healun.2018.02.006_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1469-0691.2005.01128.x","article-title":"Aspergillus infections in lung transplant recipients: risk factors and outcome","volume":"11","author":"Sole","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.healun.2018.02.006_bib35","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/jac\/dkw099","article-title":"Utility of voriconazole therapeutic drug monitoring: a meta-analysis","volume":"71","author":"Luong","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.healun.2018.02.006_bib36","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/ajt.12691","article-title":"Epidemiology of invasive mold infections in lung transplant recipients","volume":"14","author":"Doligalski","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.02.006_bib37","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3109\/00365548.2012.691207","article-title":"Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients","volume":"44","author":"Tofte","year":"2012","journal-title":"Scand J Infect Dis"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249818313561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249818313561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:36:35Z","timestamp":1760949395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249818313561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1053249818313561"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2018.02.006","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A strategy for prevention of fungal infections in lung transplantation: Role of bronchoalveolar lavage fluid galactomannan and fungal culture","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}